Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,080.00
+10.00 (0.16%)
At close: Dec 5, 2025

Kyongbo Pharmaceutical Market Cap

Kyongbo Pharmaceutical has a market cap or net worth of 145.35 billion as of December 5, 2025. Its market cap has decreased by -19.15% in one year.

Market Cap
145.35B
Enterprise Value
264.84B
Revenue
252.20B
Ranking
n/a
PE Ratio
61.01
Stock Price
6,080.00

Market Cap Chart

Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 145.35B, a decrease of -82.25%. That is a compound annual growth rate of -15.25%.

History

DateMarket Cap% Change
Dec 5, 2025145.35B-2.25%
Dec 30, 2024148.70B-25.86%
Dec 28, 2023200.58B-16.10%
Dec 29, 2022239.07B-6.98%
Dec 30, 2021257.00B-34.25%
Dec 30, 2020390.88B97.94%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 76.57T
Celltrion 40.30T
ALTEOGEN 27.86T
ABL Bio 11.02T
SK Biopharmaceuticals 10.53T
Yuhan 8,955.73B
LigaChem Biosciences 6,907.33B
HLB Co., Ltd. 6,670.96B
Market Cap Rankings